Michel Fortin

Kawecki F, Clafshenkel WP, Fortin M, Auger FA, Fradette J

Biomimetic Tissue-Engineered Bone Substitutes for Maxillofacial and Craniofacial Repair: The Potential of Cell Sheet Technologies.

Adv Healthc Mater, 7 (6), p. e1700919, 2018, ISSN: 2192-2640.

Résumé | Liens:

Galbraith T, Clafshenkel WP, Kawecki F, Blanckaert C, Labbe B, Fortin M, Auger FA, Fradette J

A Cell-Based Self-Assembly Approach for the Production of Human Osseous Tissues from Adipose-Derived Stromal/Stem Cells.

Adv Healthc Mater, 6 (4), 2017, ISSN: 2192-2640.

Résumé | Liens:

Chouinard AF, Giasson L, Fortin M

Hyperbaric oxygen therapy for head and neck irradiated patients with special consideration for oral and maxillofacial treatments

J Can Dent Assoc, 82 , p. g24, 2016, ISSN: 0709-8936.

| Liens:

Fortin M, Rousseau A

Ostéonécrose des mâchoires associée aux médicaments anti-résorptions

L'articulé, Journal de la société dentaire de Québec, (Août), p. 1,3-7, 2016.

Bouchard C, Fortin M

CTX as a marker for BRONJ.

J Can Dent Assoc, 79 , p. d173, 2013, ISSN: 0709-8936.

| Liens:

Bouchard C, Fortin M

Traumatismes au nerf alvéolaire inférieur et au nerf lingual : diagnostic et prise en charge

L'articulé, Journal de la société dentaire de Québec, (Avril), 2010.

Fortin M

Les biphosphonates.

L'articulé, Journal de la société dentaire de Québec, 27 (2), 2009.

Marx RE, Sawatari Y, Fortin M, Broumand V

Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.

J Oral Maxillofac Surg, 63 (11), p. 1567-75, 2005, ISSN: 0278-2391.

Résumé | Liens:

Caissie R, Goulet J, Fortin M, Morielli D

Iatrogenic paresthesia in the third division of the trigeminal nerve: 12 years of clinical experience.

J Can Dent Assoc, 71 (3), p. 185-90, 2005, ISSN: 0709-8936.

Résumé | Liens: